Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom.
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Strategic Partnerships
1 month ago Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom.
Related
Bitcoin no longer plays gold’s game
2 hours ago
